Literature DB >> 8161723

A comparison of metabolic control by continuous and intermittent therapies in acute renal failure.

W R Clark1, B A Mueller, K J Alaka, W L Macias.   

Abstract

Azotemia control provided by blood pump-assisted continuous hemofiltration has not been rigorously compared with that provided by intermittent hemodialysis (IHD) for critically ill patients with acute renal failure (ARF). The metabolic control achieved by continuous venovenous hemofiltration (CVVH) and IHD was compared. In ARF patients treated with CVVH (N = 11), the normalized daily dose of therapy was 0.59 +/- 0.23 (mean +/- SD) and the normalized protein catabolic rate was 1.82 +/- 0.95 g/kg per day. The serum urea nitrogen concentration (SUN) declined with CVVH from an initial value of 114 +/- 32 to 79 +/- 17 mg/dL at steady state (SUNs). The initial analysis was a theoretical comparison between CVVH azotemia control and the control that would have been provided by IHD. Simulated IHD data were generated by conventional urea kinetic methods. The peak concentration hypothesis was invoked to compare CVVH SUNs and the peak IHD SUN (SUNp). A simulated IHD frequency of five times or more weekly was required to achieve a SUNp that did not differ from the CVVH SUNs. A similar comparison between the CVVH group and a separate group of ARF patients (N = 11) who received IHD was also performed. In the latter group, the normalized protein catabolic rate and the normalized daily dose of therapy were similar to those of the CVVH group. The SUNp (101 +/- 12 mg/dL) in the IHD group was significantly higher than the mean CVVH SUNs (P < 0.05). These data suggest that intensive hemodialysis is required to provide azotemia control similar to that provided by CVVH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161723     DOI: 10.1681/ASN.V471413

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  13 in total

Review 1.  Renal replacement therapies: physiological review.

Authors:  Claudio Ronco; Zaccaria Ricci
Journal:  Intensive Care Med       Date:  2008-09-13       Impact factor: 17.440

2.  Continuous Venous-Venous-Hemodialysis versus Intermittent-Hemodialysis in Critically Ill Patients.

Authors:  Juan Jose Olivero
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Apr-Jun

3.  Role of routine blood cultures in detecting unapparent infections during continuous renal replacement therapy.

Authors:  L Le Blanc; O Lesur; L Valiquette; C St-Pierre
Journal:  Intensive Care Med       Date:  2006-09-08       Impact factor: 17.440

4.  Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy.

Authors:  Deborah A Pasko; Mariann D Churchwell; Noha N Salama; Bruce A Mueller
Journal:  Blood Purif       Date:  2011-03-02       Impact factor: 2.614

5.  Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis.

Authors:  Rolando Claure-Del Granado; Etienne Macedo; Glenn M Chertow; Sharon Soroko; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Ravindra L Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

6.  Vancomycin dosing in an obese patient with acute renal failure: A case report and review of literature.

Authors:  Kun-Yan Xu; Dan Li; Zhen-Jie Hu; Cong-Cong Zhao; Jing Bai; Wen-Li Du
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

7.  Acute renal replacement therapy in pediatrics.

Authors:  Rajit K Basu; Derek S Wheeler; Stuart Goldstein; Lesley Doughty
Journal:  Int J Nephrol       Date:  2011-06-01

Review 8.  Pro/con debate: continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?

Authors:  Raymond Vanholder; Wim Van Biesen; Eric Hoste; Norbert Lameire
Journal:  Crit Care       Date:  2011-01-28       Impact factor: 9.097

Review 9.  Continuous haemofiltration in the intensive care unit.

Authors:  R Bellomo; C Ronco
Journal:  Crit Care       Date:  2000-10-20       Impact factor: 9.097

Review 10.  Dialysis and pediatric acute kidney injury: choice of renal support modality.

Authors:  Scott Walters; Craig Porter; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2008-05-16       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.